Clinical Trial

Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR)

Study acronym: HypERR
Recruiting
View on ClinicalTrials.gov →
Summary
In France, the treatment of chronic insomnia relies mainly on hypnotic drugs in routine care, despite the high level of iatrogenicity. Cognitive-behavioral therapy (CBT) is recommended by the HAS as a non-pharmaceutical first-line therapy for chronic insomnia. Despite evidence of their efficacy in chronic insomnia, these therapies remain underdeveloped in France (few practitioners, time-consuming for the patient). Hypnotherapy is another non-drug intervention suitable for routine outpatient care. Among the hypnosis methods practiced in France, E2R (Emotion, Regression, Repair) is a hypnotherapy method used in general practice, particularly for chronic insomnia. To date, no clinical trials have been carried out to demonstrate its effectiveness in this pathology. The HypERR study is a multicenter, randomized, open-label study designed to evaluate the efficacy of a hypotherapy method called E2R in the management of chronic insomnia, by comparing it with standard care (without hypnosis).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-20; most recent amendment 2026-03-27.
Status change: Not Yet Recruiting → Recruiting 2026-03-27
Trial Details
NCT Number NCT06898099
Lead Sponsor Rennes University Hospital
Collaborators: University of Rennes
Conditions Chronic Insomnia
Enrollment 136 participants
Start Date 2025-10-14
Primary Completion 2027-04-14 (estimated)
Study Completion 2027-04-14 (estimated)
Updated on ClinicalTrials.gov 2026-04-02